Search Press releases Keywords From To 22 Sep 2020 UCB Achieves Important Regulatory Milestone for Bimekizumab Read More 11 Sep 2020 Disposals of own shares Read More 9 Sep 2020 Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances Read More 4 Sep 2020 Disposals of own shares Read More 31 Aug 2020 Phase 3 data on VIMPAT[®] (lacosamide) in primary generalized tonic-clonic seizures published in Journal of Neurology, Neurosurgery & Psychiatry Read More 28 Aug 2020 Disposals of own shares Read More Pagination First page Previous page Previous … Page 56 Page 57 Page 58 Page 59 Current page 60 Page 61 Page 62 Page 63 Page 64 … Page 60 of 69 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
